Article
Analytical Performance of the Point-of-care BIOSYNEX COVID-19 Ag BSS for the Detection of SARS‐CoV‐2 Nucleocapsid Protein in Nasopharyngeal Swabs: A Prospective Field Evaluation During the COVID-19 Third Wave in France
2021-09-16
Abstract excerpt
<title>Abstract</title> <p><bold>Background:</bold> The accuracy and reliability of rapid diagnostic tests are critical for monitoring and diagnosing SARS-CoV-2 infection in the general population. This study aimed to evaluate the analytical performance of the <italic>BIOSYNEX COVID-19 Ag BSS</italic> (Biosynex Swiss SA, Fribourg, Switzerland) antigen rapid diagnostic test (Ag-RDT), which targets the SARS-CoV-2 N...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5da903fc-feb5-5c28-b9f2-70e1ee61c4aa
- DOI
- 10.21203/rs.3.rs-876550/v1
